“One other company i am invested in, PLX with a similar pattern, namely a surge after a (much awaited) FDA approval, to be followed by a constant share decline.
A very strange phenomenon!”
Yes sir, another example highlighting a significant pullback on FDA approval. Possibly these type of biotech companies are being shorted on “good news” knowing that their will be a period (several quarters) of time before these companies are cash flow positive. Plenty of time to cover the short position. That’s my only guess at this point.
Anyone else have a theory?
Happy Weekend all!!
News 
Market Data 
Discover 
AI
